CH610894A5 - - Google Patents

Info

Publication number
CH610894A5
CH610894A5 CH592175A CH592175A CH610894A5 CH 610894 A5 CH610894 A5 CH 610894A5 CH 592175 A CH592175 A CH 592175A CH 592175 A CH592175 A CH 592175A CH 610894 A5 CH610894 A5 CH 610894A5
Authority
CH
Switzerland
Application number
CH592175A
Inventor
Bernard Joseph Mcloughlin
Allen John Guildford
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of CH610894A5 publication Critical patent/CH610894A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/04Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH592175A 1974-05-07 1975-05-07 CH610894A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2001374A GB1452701A (en) 1974-05-07 1974-05-07 Morpholine derivatives
JP2495676A JPS52139074A (en) 1974-05-07 1976-03-08 Morpholine derivative and mental version drug composition containing same

Publications (1)

Publication Number Publication Date
CH610894A5 true CH610894A5 (fr) 1979-05-15

Family

ID=26254367

Family Applications (2)

Application Number Title Priority Date Filing Date
CH592175A CH610894A5 (fr) 1974-05-07 1975-05-07
CH22779A CH634569A5 (de) 1974-05-07 1979-01-10 Verfahren zur herstellung von morpholinderivaten.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH22779A CH634569A5 (de) 1974-05-07 1979-01-10 Verfahren zur herstellung von morpholinderivaten.

Country Status (20)

Country Link
US (1) US4010266A (fr)
JP (2) JPS50154273A (fr)
AR (1) AR209436A1 (fr)
AT (1) AT344188B (fr)
BE (1) BE828822A (fr)
CA (1) CA1067075A (fr)
CH (2) CH610894A5 (fr)
DD (1) DD121641A5 (fr)
DE (1) DE2519101A1 (fr)
DK (1) DK198675A (fr)
FI (1) FI751344A (fr)
FR (1) FR2269953B1 (fr)
GB (1) GB1452701A (fr)
HK (1) HK5580A (fr)
IN (1) IN141021B (fr)
KE (1) KE3021A (fr)
LU (1) LU72408A1 (fr)
NL (1) NL7505140A (fr)
SE (1) SE425312B (fr)
ZA (1) ZA752388B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4088814A (en) * 1974-05-07 1978-05-09 Imperial Chemical Industries Limited Morpholine derivatives
JPS5266991U (fr) * 1975-11-13 1977-05-18
AU508678B2 (en) * 1976-07-14 1980-03-27 Imperial Chemical Industries Limited Anorexiants
IE50355B1 (en) * 1979-10-20 1986-04-02 Wyeth John & Brother Ltd Morpholine derivatives
JPH07503461A (ja) * 1992-01-28 1995-04-13 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー カルシウムチャンネル拮抗薬としての化合物
US6048859A (en) * 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
IL112778A0 (en) * 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
WO1998007710A1 (fr) * 1996-08-23 1998-02-26 Neurosearch A/S Derives de la thiazepine, de l'oxazepine ou de la morpholine disubstituee, preparation et utilisation de ces derniers comme antagonistes des recepteurs de la dopamine d4
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
AU2001290873B2 (en) 2000-09-11 2006-07-27 Sepracor Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2255077A (en) * 1938-03-21 1941-09-09 Du Pont Film Mfg Corp Filter dyes for color photography

Also Published As

Publication number Publication date
US4010266A (en) 1977-03-01
CA1067075A (fr) 1979-11-27
AT344188B (de) 1978-07-10
SE425312B (sv) 1982-09-20
FR2269953B1 (fr) 1978-10-06
AU8021575A (en) 1976-10-21
SE7505237L (sv) 1975-11-10
HK5580A (en) 1980-02-29
CH634569A5 (de) 1983-02-15
DK198675A (da) 1975-11-08
LU72408A1 (fr) 1976-11-11
GB1452701A (en) 1976-10-13
JPS50154273A (fr) 1975-12-12
FR2269953A1 (fr) 1975-12-05
JPS52139074A (en) 1977-11-19
ZA752388B (en) 1976-03-31
AR209436A1 (es) 1977-04-29
FI751344A (fr) 1975-11-08
ATA341575A (de) 1977-11-15
IN141021B (fr) 1977-01-08
NL7505140A (nl) 1975-11-11
DD121641A5 (fr) 1976-08-12
KE3021A (en) 1980-03-14
BE828822A (fr) 1975-11-07
DE2519101A1 (de) 1975-11-20

Similar Documents

Publication Publication Date Title
AR199073A1 (fr)
BR7403145A (fr)
BG26364A3 (fr)
CH576222A5 (fr)
AU482171A (fr)
BE829579A (fr)
BG19619A1 (fr)
BG19905A1 (fr)
BG19932A1 (fr)
BG20148A1 (fr)
BG20150A1 (fr)
BG20706A1 (fr)
BG20739A1 (fr)
BG20921A1 (fr)
BG20937A1 (fr)
BG20944A1 (fr)
AU479468A (fr)
BG21307A1 (fr)
BG21626A1 (fr)
BG21701A1 (fr)
BG21801A1 (fr)
BG22024A1 (fr)
BG22310A1 (fr)
AU480049A (fr)
BG21264A1 (fr)

Legal Events

Date Code Title Description
PL Patent ceased